Gain Therapeutics Receives Approval to Commence Phase 1 Clinical Study of GT-02287 from the Human Research Ethics Committee (HREC) in Australia

Scroll Top

Precision Medicine Online

Sep 15 2023

May 14, 2025

https://www.bioworld.com/articles/720169-other-news-to-note-for-may-14-2025?v=preview

May 12, 2025

https://www.ddw-online.com/webinar-the-challenges-and-opportunities-in-neuroscience-drug-discovery-34758-202505/

March 19, 2025

https://parkinsonsnewstoday.com/news/first-parkinsons-patient-dosed-clinical-trial-gt-02287/